Akeso, Inc.

HK$85.25As of Sun 8 Nov 2026, 12:00 UTC
HKEX:9926Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 7Y CAGR 19.82%
Div yield —
ROE (13.59%)
Biotechnology
Beta (5Y) 0.06
PE TTM —
TSR TTM (24.82%)
Mkt cap HK$80.23B
ROIC (25.36%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$85
0.13%
(89.12%)
Hold 1|10|9|10|4
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
1.09
1.08
1.10
1.11
18.92%
11.21%
9.98%
9.99%
Revenue¥B
6.724
6.907
6.886
7.177
10.79%
9.42%
8.68%
8.29%
Peers (US$10.23B)
Cap (US$)
PE
19.18B
107.5x
10.29B
76.81x
Capital
TTM
5Y
10Y
Leveragex
1.025
0.043
0.038
EBIT/Intx
0.550
0.379
0.282
Own earn%
(46.34)
(70.95)
(72.55)
Sh yield%
24.55
37.09
37.63
Owners
Insiders/Inst%
9.91
54.13
Short interest%
1.55
SBC / revenue%
3.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
16
Op margin range%
3–12
$1 testx
—
Incr. ROIC%
24